Patents by Inventor Xuguang Li
Xuguang Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240141931Abstract: A constant value method for detecting and evaluating internal leakage in a hydraulic cylinder and a detection device. The method comprises: step (1) measuring an accurate pressure drop value ?p of the internal leakage in the hydraulic cylinder; step (2), determining whether the detected hydraulic cylinder meets a standard: if the product of the accurate pressure drop value ?p of the internal leakage in the hydraulic cylinder and a corresponding hydraulic stroke L, is less than a standard parameter C for evaluating the internal leakage in the hydraulic cylinder, C = 4 ? QtK ? ? D 2 , the internal leakage in me hydraulic cylinder meets the standard. Otherwise, the internal leakage in the hydraulic cylinder does not meet the standard. The detection device comprises a motor, a hydraulic pump, a directional valve, a detected part, a pipeline disassembly joint and a pressure sensor.Type: ApplicationFiled: January 9, 2024Publication date: May 2, 2024Inventors: Bing XU, Xuguang LI, Junhui ZHANG, Huaizhi ZONG, Xinlei XU, Weidi HUANG
-
Publication number: 20240100630Abstract: The present application relates to a laser cutting head with a variable spot trajectory shape and a cutting process, belonging to the field of laser cutting processing. The technical solution is that a laser cutting head with a variable spot trajectory shape includes a beam shaper, a trajectory control assembly and a focusing assembly that are successively arranged in an optical path direction; the trajectory control assembly includes a reflecting lens, an X-axis galvanometer and a Y-axis galvanometer; a rotation axis of the X-axis galvanometer is a vertical axis; a rotation axis of the Y-axis galvanometer is a horizontal axis; a reflection surface of the reflecting lens is opposite to a reflection surface of the X-axis galvanometer, and a reflection surface of the Y-axis galvanometer is opposite to the reflection surface of the X-axis galvanometer.Type: ApplicationFiled: November 9, 2021Publication date: March 28, 2024Inventors: Xuguang YANG, Chengshun ZHANG, Chuanming CHEN, Qinmin ZHANG, Mandun NIU, Chi MA, Wenqi JIA, Wei LI, Yongze ZHANG
-
Publication number: 20230407193Abstract: A method for processing a gasoline fraction includes the steps of: a) reacting the gasoline fraction in an aromatization unit, and separating the resulting reaction product to obtain a C4? component, a C5 component, a C6-C7 component, a C8 component and a C9+ component; b) reacting the resulting C6-C7 component and the C9+ component in a cracking and aromatics conversion unit, and separating the resulting reaction product to obtain a C4? component, a C5 component, a C6-C7 component, a C8 component and a C9+ component; and c) recycling at least a part of at least one of the C6-C7 component and the C9+ component from step b) to the cracking and aromatics conversion unit of step b) for further reaction. The method can convert the gasoline fraction into C8 aromatic hydrocarbon(s) and produce light olefins and a high-quality light gasoline as byproducts.Type: ApplicationFiled: October 22, 2021Publication date: December 21, 2023Inventors: Jingqiu LI, Dejin KONG, Xuguang LI, Zongshuang WANG, Huaying LI, Weiyi TONG
-
Publication number: 20230392086Abstract: A method for processing a hydrocarbon-containing mixture includes the steps of: I) separating the hydrocarbon-containing mixture into a light fraction and a heavy fraction; II) reacting the light fraction from step I) in an aromatization unit and separating the resulting reaction product into a C5? component and a C6+ component; III) reacting the heavy fraction from step I) and optionally the C6+ component from step II) in an aromatics conversion unit and separating the resulting reaction product into a C5? component, a C6-C7 component, a C8 component, and a C9+ component; and IV) optionally, steam cracking or catalytic cracking one or both of the C5? component from step II) and the C5? component from step III). The method can convert low-value hydrocarbon mixtures into C8 aromatic hydrocarbons and cracking raw materials, and improve the product value. A system for practicing this method is also provided.Type: ApplicationFiled: October 13, 2021Publication date: December 7, 2023Inventors: Jingqiu LI, Dejin KONG, Xuguang LI, Zongshuang WANG, Huaying LI
-
Patent number: 11529609Abstract: A preparation method of a resin-based iron oxide-containing composite phosphate removal adsorbent is provided. An alkaline anion resin is taken as a base, a potassium ferrate is used as an iron source, and a characteristics of ferrate ions easily adsorbed on a surface of the anion resin are utilized to prepare resin-based iron oxide-containing composite phosphate removal adsorbent by one-step in-situ hydrolysis precipitation, compared with the related art, a preparation process of the disclosure is relatively simpler, a time period is shorter, and a production cost is lower. It has a strong ability to eliminate interference from other anions in the waste effluents, and it has a strong adsorption capacity, fast adsorption speed and large adsorption capacity for the phosphate. Moreover, it has the advantages of strong regeneration ability and multiple repeated use times.Type: GrantFiled: August 31, 2020Date of Patent: December 20, 2022Assignee: HUAZHONG AGRICULTURAL UNIVERSITYInventors: Guanglong Liu, Xuguang Li, Haijian Bing, Changquan Wang, Zhenghua Zhe, Tao Li, Renkai Yan, Jianwei Zhao, Yumei Hua, Dionysios (Dion) D. Dionysiou, Mallikarjuna N. Nadagouda, Bangxing Ren, Wael Abdelraheem
-
Patent number: 11413345Abstract: A synthetic hemagglutinin (sHA) which represents the highest degree of conservation in the HA sequences of all Influenza B viruses (IVB) based on comprehensive bioinformatics analyses was cloned into an adenoviral vector. The recombinant adenovirus carrying the sHA gene was then delivered intransallyintranasally into DAB/2 mice. The animals were challenged with 5xLD50 influenza B viruses. We have found that the synthetic HA vaccines afford 100% protection against lethal challenge whereas 50% mice died in the control group. Furthermore, no virus was found in the lung of the vaccinated group while significant lung viruses were found in all mice of the controlled group. Consistent with the survival data and virus titre, severe pneumonia was found in all mice of the control group while no pathologic observation was made in animals receiving the vaccines.Type: GrantFiled: November 16, 2018Date of Patent: August 16, 2022Assignee: Her Majestry the Queen in Right of Canada as Represented by the Minister of HealthInventors: Xuguang Li, Gary Van Domselaar, Adrian Zetner
-
Patent number: 11390893Abstract: The present application relates to a method for extracting coenzyme Q10 and a phospholipid from a coenzyme Q10 fermentation bacterium powder. The method is characterized in that the fermentation bacterium powder of a coenzyme Q10 production strain is subjected to extraction with a mixed solvent of which the three-dimensional Hansen solubility parameter is between 21 and 23 (J/cm3)1/2 and the hydrogen bonding solubility parameter thereof is between 10 and 12 (J/cm3)1/2. The present invention can efficiently extract two products, namely coenzyme Q10 and a phospholipid, from the coenzyme Q10 fermentation bacterium powder; the process thereof is highly operable, easy to be industrialized, and can provide a product with high purity and yield, having great economic benefit.Type: GrantFiled: May 23, 2018Date of Patent: July 19, 2022Assignees: ZHEJIANG NHU CO. LTD., ZHEJIANG UNIVERSITY, HEILONGJIANG NHU BIOTECHNOLOGY CO. LTD., SHANGYU NHU BIOLOGICAL CHEMICAL CO., LTD.Inventors: Shenfeng Yuan, Yang Yao, Yi Min, Baishan Hu, Zhaofeng Chen, Yong Li, Qichuan Li, Yunxuan Luo, Jinyang Zhang, Xuguang Li, Shichun Tu
-
Patent number: 11088552Abstract: The present application discloses a charging method, a terminal, and a charging adapter. The terminal includes: a USB port, and a processor and a logical circuit respectively coupled to the USB port, where the logical circuit supports a target fast charging protocol, the processor is connected to the logical circuit, the USB port is configured to connect to a charging adapter, and the target fast charging protocol is a fast charging protocol supporting a capability of continuous communication between the terminal and the charging adapter.Type: GrantFiled: May 1, 2019Date of Patent: August 10, 2021Assignee: HUAWEI TECHNOLOGIES CO., LTD.Inventors: Xuguang Li, Guangwei Zheng, Xuegang Yang, Daohai Xu
-
Publication number: 20210154643Abstract: A preparation method of a resin-based iron oxide-containing composite phosphate removal adsorbent is provided. An alkaline anion resin is taken as a base, a potassium ferrate is used as an iron source, and a characteristics of ferrate ions easily adsorbed on a surface of the anion resin are utilized to prepare resin-based iron oxide-containing composite phosphate removal adsorbent by one-step in-situ hydrolysis precipitation, compared with the related art, a preparation process of the disclosure is relatively simpler, a time period is shorter, and a production cost is lower. It has a strong ability to eliminate interference from other anions in the waste effluents, and it has a strong adsorption capacity, fast adsorption speed and large adsorption capacity for the phosphate. Moreover, it has the advantages of strong regeneration ability and multiple repeated use times.Type: ApplicationFiled: August 31, 2020Publication date: May 27, 2021Inventors: Guanglong Liu, Xuguang Li, Haijian Bing, Changquan Wang, Zhenghua Zhe, Tao Li, Renkai Yan, Jianwei Zhao, Yumei Hua, Dionysios (Dion) D. Dionysiou, Mallikarjuna N. Nadagouda, Bangxing Ren, Wael Abdelraheem
-
Publication number: 20200399667Abstract: The present application relates to a method for extracting coenzyme Q10 and a phospholipid from a coenzyme Q10 fermentation bacterium powder. The method is characterized in that the fermentation bacterium powder of a coenzyme Q10 production strain is subjected to extraction with a mixed solvent of which the three-dimensional Hansen solubility parameter is between 21 and 23 (J/cm3)1/2 and the hydrogen bonding solubility parameter thereof is between 10 and 12 (J/cm3)1/2. The present invention can efficiently extract two products, namely coenzyme Q10 and a phospholipid, from the coenzyme Q10 fermentation bacterium powder; the process thereof is highly operable, easy to be industrialized, and can provide a product with high purity and yield, having great economic benefit.Type: ApplicationFiled: May 23, 2018Publication date: December 24, 2020Inventors: Shenfeng YUAN, Yang YOA, Yi MIN, Baishan HU, Zhaofeng CHEN, Yong LI, Qichuan LI, Yunxuan LUO, Jinyang ZHANG, Xuguang LI, Shichun TU
-
Publication number: 20200306363Abstract: A synthetic hemagglutinin (sHA) which represents the highest degree of conservation in the HA sequences of all Influenza B viruses (IVB) based on comprehensive bioinformatics analyses was cloned into an adenoviral vector. The recombinant adenovirus carrying the sHA gene was then delivered intransallyintranasally into DAB/2 mice. The animals were challenged with 5xLD50 influenza B viruses. We have found that the synthetic HA vaccines afford 100% protection against lethal challenge whereas 50% mice died in the control group. Furthermore, no virus was found in the lung of the vaccinated group while significant lung viruses were found in all mice of the controlled group. Consistent with the survival data and virus titre, severe pneumonia was found in all mice of the control group while no pathologic observation was made in animals receiving the vaccines.Type: ApplicationFiled: November 16, 2018Publication date: October 1, 2020Inventors: Xuguang Li, Gary Van Domselaar, Adrian Zetner
-
Publication number: 20190260212Abstract: The present application discloses a charging method, a terminal, and a charging adapter. The terminal includes: a USB port, and a processor and a logical circuit respectively coupled to the USB port, where the logical circuit supports a target fast charging protocol, the processor is connected to the logical circuit, the USB port is configured to connect to a charging adapter, and the target fast charging protocol is a fast charging protocol supporting a capability of continuous communication between the terminal and the charging adapter.Type: ApplicationFiled: May 1, 2019Publication date: August 22, 2019Inventors: Xuguang LI, Guangwei ZHENG, Xuegang YANG, Daohai XU
-
Publication number: 20180191461Abstract: An interface data transmission method, a data transmission interface, and an interface system, where the method includes encoding, by a transmit end in the interface system, original data to obtain encoded data, where the encoding operation includes grouping the original data, the encoded data includes a termination code block indicating that a transmission process of the original data terminates, and the termination code block includes a first synchronization header, a code block type field indicating that the transmission process terminates, and a termination payload, and the first synchronization header indicates that a payload following the first synchronization header includes a control-type payload, and the termination payload may be used to carry a remaining code block after the original data is grouped, and sending, by the transmit end, the encoded data to a receive end.Type: ApplicationFiled: December 27, 2017Publication date: July 5, 2018Inventors: Xuguang Li, Guangwei Zheng
-
Patent number: 9897606Abstract: Two universally conserved sequences from influenza type A neuraminidases were identified by large scale sequence analysis then chemically modified and conjugated to carrier proteins to generate mono-specific and monoclonal antibodies. The two antibodies, one targeting the N-terminus of the type A neuraminidase and the other sequence close to enzymatic active site, were capable of binding to all 9 subtypes of neuraminidase while demonstrating remarkable specificity against the viral neuraminidase sequences since no cross-reactivity against allantoic proteins was observed. Quantitative analyses of NA using slot blot suggest that the antibodies can be used for NA antigen quantitation in vaccines. These represent the first time the antibody-based immunoassay can be used for NA quantitative determination.Type: GrantFiled: July 26, 2016Date of Patent: February 20, 2018Inventors: Xuguang Li, Runtao He, Gary Van Domselaar
-
Publication number: 20170131277Abstract: Two universally conserved sequences from influenza type A neuraminidases were identified by large scale sequence analysis then chemically modified and conjugated to carrier proteins to generate mono-specific and monoclonal antibodies. The two antibodies, one targeting the N-terminus of the type A neuraminidase and the other sequence close to enzymatic active site, were capable of binding to all 9 subtypes of neuraminidase while demonstrating remarkable specificity against the viral neuraminidase sequences since no cross-reactivity against allantoic proteins was observed. Quantitative analyses of NA using slot blot suggest that the antibodies can be used for NA antigen quantitation in vaccines. These represent the first time the antibody-based immunoassay can be used for NA quantitative determination.Type: ApplicationFiled: July 26, 2016Publication date: May 11, 2017Inventors: Xuguang Li, Runtao He, Gary Van Domselaar
-
Patent number: 9427462Abstract: Two universally conserved sequences from influenza type A neuraminidases were identified by large scale sequence analysis then chemically modified and conjugated to carrier proteins to generate mono-specific and monoclonal antibodies. The two antibodies, one targeting the N-terminus of the type A neuraminidase and the other sequence close to enzymatic active site, were capable of binding to all 9 subtypes of neuraminidase while demonstrating remarkable specificity against the viral neuraminidase sequences since no cross-reactivity against allantoic proteins was observed. Quantitative analyses of NA using slot blot suggest that the antibodies can be used for NA antigen quantitation in vaccines. These represent the first time the antibody-based immunoassay can be used for NA quantitative determination.Type: GrantFiled: December 1, 2014Date of Patent: August 30, 2016Assignee: Her Majesty the Queen in Right of Canada As Represented by, the Minister of HealthInventors: Xuguang Li, Runtao He, Gary Van Domselaar
-
Publication number: 20150326405Abstract: A fiber-coax unit (FCU) is coupled to an optical line terminal (OLT) and a plurality of coax network units (CNUs). The FCU receives a multicast frame from the OLT. The multicast frame includes a first multicast logical link identifier (LLID) dedicated for multicast traffic directed to CNUs. The FCU replaces the first multicast LLID in the multicast frame with a second multicast LLID corresponding to one or more multicast groups that include at least one CNU of the plurality of CNUs. The FCU transmits the multicast frame to the plurality of CNUs.Type: ApplicationFiled: December 17, 2012Publication date: November 12, 2015Inventors: Tienchuan Ko, Honger Nie, Xinyu Hu, Andrea J. Garavaglia, Stephen J. Shellhammer, Xuguang Li, Patrick Stupar
-
Publication number: 20150147784Abstract: Two universally conserved sequences from influenza type A neuraminidases were identified by large scale sequence analysis then chemically modified and conjugated to carrier proteins to generate mono-specific and monoclonal antibodies. The two antibodies, one targeting the N-terminus of the type A neuraminidase and the other sequence close to enzymatic active site, were capable of binding to all 9 subtypes of neuraminidase while demonstrating remarkable specificity against the viral neuraminidase sequences since no cross-reactivity against allantoic proteins was observed. Quantitative analyses of NA using slot blot suggest that the antibodies can be used for NA antigen quantitation in vaccines. These represent the first time the antibody-based immunoassay can be used for NA quantitative determination.Type: ApplicationFiled: December 1, 2014Publication date: May 28, 2015Inventors: Xuguang Li, Runtao He, Gary Van Domselaar
-
Patent number: D1016773Type: GrantFiled: May 5, 2022Date of Patent: March 5, 2024Assignee: SHENZHEN TCL DIGITAL TECHNOLOGY LTD.Inventors: Zhonghao Huang, Jingran Zhang, Hairong Lu, Xuguang Yang, Zhengxin Li
-
Patent number: D1020672Type: GrantFiled: April 24, 2022Date of Patent: April 2, 2024Assignee: SHENZHEN TCL NEW TECHNOLOGY CO., LTD.Inventors: Zhonghao Huang, Jingran Zhang, Hairong Lu, Xuguang Yang, Zhengxin Li